Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Entacapone GPO vs Comtan under fasting conditions
TCTR20200302001Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of entacapone in Parkinson's disease (PD) (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on TCTR20200302001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200302001.